Aortic stiffness in young patients with heterozygous familial hypercholesterolemia

被引:118
|
作者
Pitsavos, C [1 ]
Toutouzas, K [1 ]
Dernellis, J [1 ]
Skoumas, J [1 ]
Skoumbourdis, E [1 ]
Stefanadis, C [1 ]
Toutouzas, P [1 ]
机构
[1] Univ Athens, Hippakration Hosp, Dept Cardiol, GR-10679 Athens, Greece
关键词
D O I
10.1016/S0002-8703(98)70274-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dyslipidemia is a primary risk factor for the development of atherosclerosis. Aortic distensibility is an important determinant of left ventricular function and coronary blood flow whose possible alterations in patients with dyslipidemia have not been fully investigated. Methods To assess the effect of dyslipidemia on the elastic properties of the aorta, we studied 60 patients (mean age 37 +/- 11 years) with heterozygous familial hypercholesterolemia and no manifest arterial disease and compared them with 20 of their normolipidemic siblings (mean age 34 +/- 10 years). Two indexes of the aortic elastic properties were measured: aortic distensibility was calculated by use of the formula: 2 x (AoS-AoD)/PP x AoD, and aortic stiffness index was calculated by use of the formula: In (SBP/DBP)/(AoS-AoD)/AoD, where AoS and AoD ore aortic root end-systolic and end-diastolic diameters, respectively, SEP and DBP are systolic and diastolic arterial pressure, respectively, and PP is pulse pressure. Internal aortic root diameters were measured at 3 cm above the aortic valve by use of two-dimensional guided M-mode transthoracic echocardiography, and arterial pressure was measured simultaneously at the brachial artery by sphygmomanometry. Results The mean aortic systolic and diastolic diameter index did not differ signifficantly between the two groups. In contrast, aortic distensibility was found to be significantly reduced in subjects with isolated familial hypercholesterolemia compared with that in the control group (2.15 +/- 1.72 cm(2).dynes.10(-6)vs 3.18 +/- 1.58 cm(2).dynes(-1).10(-6), p < 0.02), In addition, the mean aortic stiffness index was double in patients with familial hypercholesterolemia compared with that in normolipidemic subjects. Conclusions severe dyslipidemia does not overtly influence aortic dimensions but leads to impairment of aortic elastic properties before the occurrence of clinical manifestations of atherosclerotic disease.
引用
下载
收藏
页码:604 / 608
页数:5
相关论文
共 50 条
  • [1] Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
    Ershova, Alexandra I.
    Meshkov, Alexey N.
    Rozhkova, Tatyana A.
    Kalinina, Maria V.
    Deev, Alexander D.
    Rogoza, Anatoliy N.
    Balakhonova, Tatyana V.
    Boytsov, Sergey A.
    PLOS ONE, 2016, 11 (07):
  • [2] AORTIC COMPLIANCE IN YOUNG-PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    LEHMANN, ED
    WATTS, GF
    FATEMILANGROUDI, B
    GOSLING, RG
    CLINICAL SCIENCE, 1992, 83 (06) : 717 - 721
  • [3] CHANGES IN AORTIC STIFFNESS IN CHILDREN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Galimova, L.
    Sadykova, D.
    Slastnikova, E.
    ATHEROSCLEROSIS, 2019, 287 : E104 - E104
  • [4] P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
    A. I. Ershova
    A. N. Meshkov
    T. A. Rozhkova
    A. N. Rogoza
    T. V. Balakhonova
    S. A. Boytsov
    Artery Research, 2011, 5 (4) : 169 - 169
  • [5] Effects of pravastatin on thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia
    Pitsavos, CE
    Aggeli, KI
    Barbetseas, JD
    Skoumas, IN
    Lambrou, SG
    Frogoudaki, AA
    Stefanadis, CI
    Toutouzas, PK
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (12): : 1484 - 1488
  • [6] Supravalvular and valvular aortic stenosis in heterozygous familial hypercholesterolemia
    Rafeiyian, Sima
    Mojtahedzadeh, Saeed
    Hekmat, Manouchehr
    Naderi, Nasim
    Nobahar, Rezvan
    Hashemi, Mohammad Jafar
    Kouhi, Ali
    MEDICAL PRINCIPLES AND PRACTICE, 2007, 16 (04) : 315 - 317
  • [7] Prevalence, distribution and correlates of thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia
    Lambrou, SG
    Aggeli, C
    Panagiotakos, D
    Skoumas, I
    Frogoudaki, A
    Pitsavos, C
    Stefanadis, C
    Toutouzas, P
    EUROPEAN HEART JOURNAL, 2002, 23 : 55 - 55
  • [8] Heterozygous familial hypercholesterolemia
    Ozcan, Ozgr Ulas
    Gulec, Sadi
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 : 10 - 18
  • [9] Heterozygous Familial Hypercholesterolemia
    Onorato, Angela
    Sturm, Amy C.
    CIRCULATION, 2016, 133 (14) : E587 - E589
  • [10] Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Wiegman, Albert
    Caprio, Sonia
    Cariou, Bertrand
    Averna, Maurizio
    Poulouin, Yann
    Scemama, Michel
    Manvelian, Garen
    Garon, Genevieve
    Daniels, Stephen
    JAMA PEDIATRICS, 2024, 178 (03) : 283 - 293